SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Aurora Biosciences (ABSC) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (166)10/1/1998 1:14:00 AM
From: Vector1  Respond to of 359
 
Richard,
The market is starting to understand that the biotechs like the pharmacuedicals are not as sensitive as most businesses to weakness in the rest of the world.
I loaded up on this stock at $4 and am feeling pretty good. The risk reward is excellent.
V1



To: Richard Haugland who wrote (166)10/6/1998 6:22:00 PM
From: Richard Haugland  Read Replies (1) | Respond to of 359
 
Aurora Biosciences Announces Conclusion of Collaboration With Packard Instrument Company

biz.yahoo.com

To me this announcement indicates that these companies will now be competitors since Packard is also in the high-throughput screening arena with the same target customers. Hopefully ABSC now has the internal expertise to do this development in house.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News